Potassium channel inhibitors

Details Potassium channel inhibitors Potassium channel inhibitors

2005-02-22

2005-02-22

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C514S258100, C514S299000, C544S235000, C544S253000, C544S349000, C546S112000

Reexamination Certificate

active

06858610

ABSTRACT:
Compounds as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.

REFERENCES:
patent: 2298443 (1942-10-01), Weissberger
patent: 4422871 (1983-12-01), Schirmer et al.
patent: 4975453 (1990-12-01), Becker et al.
patent: 5006512 (1991-04-01), Ohnishi
patent: 5215985 (1993-06-01), Murphy et al.
patent: 5234947 (1993-08-01), Cherksey
patent: 5242947 (1993-09-01), Cherksey et al.
patent: 5310932 (1994-05-01), Atwal et al.
patent: 5328830 (1994-07-01), Janis et al.
patent: 5356775 (1994-10-01), Herbert et al.
patent: 5401758 (1995-03-01), Atwal et al.
patent: 5401848 (1995-03-01), Atwal
patent: 5451580 (1995-09-01), Murphy et al.
patent: 5453421 (1995-09-01), Atwal et al.
patent: 5486515 (1996-01-01), Brown et al.
patent: 6015822 (2000-01-01), Brendel et al.
patent: 6083986 (2000-07-01), Castel et al.
patent: 6333337 (2001-12-01), Gross et al.
patent: 0 286 278 (1988-10-01), None
patent: 0 317 321 (1989-05-01), None
patent: 0 321 175 (1989-08-01), None
patent: 0 472 053 (1992-02-01), None
patent: 0 488 616 (1992-06-01), None
patent: 0 587 180 (1994-03-01), None
patent: 0 608 858 (1994-08-01), None
patent: 0915087 (1999-05-01), None
patent: WO 9518617 (1995-07-01), None
patent: WO 9526342 (1995-10-01), None
patent: WO 9621640 (1996-07-01), None
patent: WO 9636596 (1996-11-01), None
patent: WO 9725893 (1997-07-01), None
patent: WO 9725983 (1997-07-01), None
patent: WO 9726300 (1997-07-01), None
patent: WO 9804521 (1998-02-01), None
patent: WO 9836749 (1998-08-01), None
patent: WO 9937607 (1999-07-01), None
patent: WO 0012077 (2000-03-01), None
Dialog Web Output, Derwent World Patents Index, Records for: pn=EP 915087, 1999.
International Search Report PCT/US 00/34765, 2000.
Still, et al., “Rapid Chromatographic Technique for Preparative Separation with Moderate Resolution,” J. Org. Chem., vol. 43, No. 14, 1978, 2923-2925.
Castle, et al., “Characterization of 4-Aminopyridne Block of the Transient Outward K+Current in Adult Rat Ventricular Myocytes,” The Journal of Pharmacology And Experimental, vol. 264, No. 3, 1450-1459, 1993.
Deal, et al., “Molecular Physiology of Cardiac Potassium Channels,” Physiological Reviews, vol. 76, No. 1, Jan. 1996, 49-67.
Wang, et al, “Sustained Depolarization-Induced Outward Current in Human Atrial Myocytes, Evidence for a Novel Delayed Rectified K+Current Similar to Kv1.5 Cloned Channel Current,” Circulation Research, vol. 73, No. 6, Dec. 1993, 1061-1076.
Hamill, “Improved Patch-Clamp Techniques for High-Resolution Current Recording from Cells and Cell-Free Membrane Patches,” Pflüger Archiv, (1981) 391:85-100.
Fedida, et al., “Identity of a Novel Delayed Rectifier Current From Human Heart With a Cloned K+Channel Current,” Circulation Research, vol. 73, No. 1, Jul. 1993, 210-216.
Chandy, et al., “Voltage-Gated Potassium Channels Are Required For Human T. Lymphocyte Activation,” J. Exp. Med., vol. 160, Aug. 1984, 369-385.
Sanguinetti, “Modulation of Potassium Channels by Antiarrhythmic and Antihypertensive Drugs,” Hypertension, vol. 19, No. E, Mar. 1992, 228-236.
Lynch, et al., “Therapeutic Potential of modulating Potassium Currents in the Diseased Myocardium,” The FASEB Journal, vol. 6, Aug. 1992, 2952-2960.
Colatsky, et al, “Channel Specificity in Antiarrhythmic Drug Action,” Circulation, vol. 82, No. 6, Dec. 1990, 2235-2242.
Halliwell, “K+Channels in the Central Nervous System,” 348-381, 1988.
Amos, et al. “Differences Between Outward Currents of Human Atrial and Subepicardial Ventricular Myocytes,” Journal of Physiology, (1986), 491.1, 31-50.
Wang, et al., “Effects of Flecanide, Quinidine, and 4-Aminopyridine on Transient Outward and Ultrarapid Delayed Rectifier Currents in Human Atrial Myocytes,” The Journal of Pharmacology and Experimental Therapeutics, vol. 272, No. 1, 184-196, 1995.
Lin, et al., Voltage-gated Potassium Channel Regulate Calcium-dependent Pathways Involved in Human T Lymphocyte Activation, J. Exp. Med., vol. 177, 637-645, 1993.
Kaczorowki, et al., “lymphocyte Ion Channels as a Target for Immunosuppression,” Perspective in Drug Discovery and Design 2 (1994) 233-248.
Leonard, et al., Selective Blockers of voltage-Gated K+Channels Depolarize Human T Lymphocytes: Mechanism of the Antiproliferative Effect of Charybdotoxin, vol. 89, 10094-10098, Nov. 1992.
Doupnik, et al., “The Inward Rectifier Potassium Channel Family,” Current Opinion in Neurobiology, 1995, 5:268-277.
Chandy, et al., “Voltage-Gated Potassium Channel Genes,” Handbook of Receptors and Channels, 1-71, 1995.
Epps et al., Chemistry and Physics of Lipids, 69(1994) pp. 137-150.
Chem. Abs., vol. 104, No. 9 Abs No. 68632 (Mar. 3, 1986).
International Search Report PCT/US97/12559, 1997.

Affiliated with

Also associated with

Rating

Potassium channel inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Potassium channel inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium channel inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3457023